Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study

CONCLUSIONS: Triplet therapy arrived in clinical practice primarily for synchronous high-volume mHSPC. Regardless of selected therapy regimen, treatment is highly effective and tolerable. Preferably therapy should be administered simultaneously, however if not possible, chemotherapy should be started first.PMID:38267304 | DOI:10.1016/j.clgc.2023.12.018

Source: Clinical Prostate Cancer - January 24, 2024 Category: Cancer & Oncology Authors: Mona Kafka Giulia Giannini Nastasiia Artamonova Hannes Neuwirt Heidemarie Ofner Gero Kramer Thomas Bauernhofer Ferdinand Luger Thomas H öfner Wolfgang Loidl Hubert Griessner Lukas Lusuardi Antonia Bergmaier Andreas Berger Thomas Winder Sarah Weiss Severi Source Type: research